share_log

XORTX Therapeutics Inc: ON FORM 13-502F3A (CLASS 3A REPORTING ISSUERS -PARTICIPATION FEE)

SEDAR ·  Mar 28, 2023 13:25
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more